Therapeutic agent

Melatonin

Also known as: Melatonin

PreliminaryEvidence level
2Registered trials
2Conditions
1Study references

Evidence Summary

Evidence Level
Preliminary
Mechanism
Enrollment: Actual, Neurological / Autonomic, Sponsor Type: Other, Unknown / General
Safety
Limited specific safety data in these populations. Review full prescribing information and consult specialist. Many agents used off-label or investigational.
Dosing
See linked studies/trials for reported doses and durations; typical protocols vary widely.
Investigational for listed conditions. 2 associated trial(s) and 1 study reference(s) in current data. Review primary sources and consult specialists before use.

Clinical Trials

2 trial(s) registered

NCT IDTitlePhaseStatus
NCT06404112RECOVER-SLEEP: Platform Protocol, Appendix_B (CPSD)Phase 2Completed
NCT06404086RECOVER-SLEEP: Platform ProtocolPhase 2Completed

Key Studies / References